Additive ManufacturingPoly-Med offers custom manufacturing of specialized materials for the medical device industry supported by innovative design and in-house resin-based & fused filament printing services.
Biomaterials & Processing Catalog
Poly-Med, Inc. produces specialized biomaterials with innovative design supported by in-house fused filament and resin-based printing services from rapid prototyping through production manufacturing.
Absorbable polymers can transform the healing process by temporarily restoring functionality in targeted areas. After use, these materials resorb within the body without a trace, minimizing the need for follow up surgical procedures.
With the ability to provide fully traceable, medical-grade filaments and resins for additive manufacturing, Poly-Med’s 3D printing materials offer distinct advantages in unique properties based on their composition, architecture, and desired performance.
On-site 3D printing engineers can translate your conceptual design into formal 3D printing file formats through the use of a variety of software solutions.
Poly-Med’s fused filament fabrication and resin-based 3D printing services offers range of build volumes, unique geometries, along with a diverse selection of medical grade polymers.
3D printing is capable of producing end use parts on-demand, increasing throughput, reducing manufacturing lead times to permit faster innovation and speed to market.
Photoset® liquid-based resin can be used in additive manufacturing methods involving UV radiation, such DLP & SLA to create high-resolution absorbable implants.
Liquid-based formulation that exhibits mechanical performance similar to TPU-based materials. Photoset® 023 can be utilized for its extended strength retention, coupled with flexibility. This material typically exhibits strength loss in 4 -6 weeks and mass loss in 6-9 months, depending on geometry, physiological environment & anatomical location.
Liquid-based formulation that exhibits mechanical performance similar to Strataprene® 5525. Photoset® 312 can be utilized for its shorter strength retention, coupled with moderate flexibility. This material typically exhibits strength loss in 2 -4 weeks and mass loss in 6-9 months, depending on geometry, physiological environment & anatomical location.
Liquid-based formulation that exhibits mechanical performance similar to polydioxanone-based polymers. Photoset® 412 can be utilized for its shorter strength retention, coupled with sufficient rigidity. This material typically exhibits strength loss in 2 -3 weeks and mass loss in 6-9 months, depending on geometry, physiological environment & anatomical location.
With the ability to convert fully traceable, implant-grade absorbable polymers & filaments into 3D printed constructs, Poly-Med’s materials offer distinct advantages in unique properties based on their composition, architecture, and desired performance.
Dioxanone-based polymer that provides the recognized performance of PDO-based polymers. Polydioxanone polymers are utilized for their extended strength retention, coupled with flexibility. This material typically exhibits strength loss in 4 -6 weeks and mass loss in 6 to 9 months, depending on processing, physiological environment, and anatomical location.
Strataprene® 5525 polymer is derived from a polyaxial block copolymer with elastic-like behavior, higher elongation, higher toughness, and lower modulus compared to standard PGLA, PLCL, or PLLA polymers. This material typically exhibits strength loss in 1 to 2 months and mass loss in 6 to 9 months, depending on processing, physiological environment, and anatomical location.
Lactide-based block copolymer that provides increased flexibility & toughness compared to standard PLGA materials. This material typically exhibits strength loss in 3 to 4 months and mass loss in 12 to 36 months, depending on processing, physiological environment, and anatomical location.
Lactide-based block copolymer that provides long-lasting performance and strength similar to PLA-based polymers. This material typically exhibits strength loss in 6 to 12 months and mass loss in 18 to 36 months, depending on processing, physiological environment, and anatomical location.
Develop your absorbable implant with Poly-Med’s portfolio of advanced bioresorbable polymers to access lattice-based infill designs to facilitate increased tissue ingrowth compared to solid parts produced via traditional injection molding. Leverage Poly-Med’s vertical integration using our 3D printing services to increase your device’s speed to market and de-risk your supply chain for commercial product supply.
Looking for more information regarding our advanced bioresorbable polymers for 3D printing? View this short article detailing our available resin-based and filament-based approaches.
Looking for a trustworthy & competent partner to co-create and manufacture your next-generation absorbable implant? Contact our team to speak to an expert.
